The Parker Institute for Cancer Immunotherapy is a renowned research institute based in San Francisco, CA. They collaborate with academic institutions, pharma companies, biotech firms, and nonprofits to develop breakthrough immune therapies that aim to transform all cancers into curable diseases. Their active research model removes barriers, fosters collaboration, and translates innovative ideas into real-world cancer treatments.
With a focus on turning the tide against cancer, the Parker Institute for Cancer Immunotherapy combines the brightest minds in the field to accelerate research and save lives faster. As an influential grant maker and research institute, they strive to push the boundaries of cancer immunotherapy by leveraging the seminal contributions of their academic collaborators and strategic partnerships across various sectors. Their mission is to develop groundbreaking immune therapies that have the potential to revolutionize cancer treatment and improve patient outcomes.
Generated from the website